ARCTURUS THERAPEUTICS HOLDIN
ARCTNASDAQ🏆 #3135 by market capEarnings Nov 9US Equity
$13.70▼ $0.72 (−5.26%)
🌙 After hours$13.58▼ 0.87%Regular close · extended-hours price shownTrack ARCT
Get earnings, price moves & breaking news on Telegram
24h▼ 5.3%
7d▲ 3.1%
14d▼ 12.2%
30d▼ 7.2%
ytd▲ 124.2%
1y▼ 25.7%
🏦Market Cap
$389M
Small Cap
📈Revenue Growth (YoY)
-51.4%
Declining
📊Gross Margin
83.2%
High
💵FCF Margin
-306.9%
Thin
⚖️P/S Ratio
16.7x
Expensive
Otter Score
76
Good
ARCTURUS THERAPEUTICS HOLDIN
ARCTAnalyst Ratings
Price
$13.70
Total
21
Raised
3
Lowered
8
Avg PT
$30.50
H / L
$41 / $20
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
BTIG | Reiterated | Buy | 2026-09-24 | $20.00 | +46.00% |
Citigroup | Upgraded | Neutral → Buy | 2026-09-24 | — | — |
B. Riley Securities | Upgraded | Neutral → Buy | 2026-03-18 | — | — |
Piper Sandler | Reiterated | Overweight | 2026-03-04 | $25.00 | +82.50% |
HC Wainwright & Co. | Reiterated | Neutral | 2025-11-11 | — | — |
Wells Fargo | Reiterated | Overweight | 2025-10-23 | — | — |
Guggenheim | Downgraded | Buy → Neutral | 2025-10-23 | — | — |
Leerink Partners | Reiterated | Outperform | 2025-08-22 | $54.00 | +294.20% |
Scotiabank | Reiterated | Sector Outperform | 2025-07-02 | $32.00 | +133.60% |
Canaccord Genuity | Reiterated | Buy | 2025-05-13 | $74.00 | +440.10% |
Cantor Fitzgerald | Reiterated | Overweight | 2025-03-07 | — | — |
Goldman Sachs | Reiterated | Sell | 2022-11-10 | $14.00 | +2.20% |
Baird | Downgraded | Neutral → Underperform | 2022-11-10 | — | — |
Barclays | Upgraded | Underweight → Equal Weight | 2022-11-02 | $25.00 | +82.50% |
Raymond James | Downgraded | Market Perform → Underperform | 2022-08-10 | — | — |
B. Riley FBR | Downgraded | Buy → Neutral | 2021-01-15 | — | — |
Roth Capital | Downgraded | Buy → Sell | 2020-12-23 | $41.00 | +199.30% |
WBB Securities | Downgraded | Strong Buy → Hold | 2020-11-25 | — | — |
Ladenburg Thalmann | Downgraded | Buy → Neutral | 2020-11-25 | — | — |
H.C. Wainwright | Reiterated | Buy | 2020-11-25 | $60.00 | +338.00% |
Miller Tabak | Downgraded | Strong Buy → Buy | 2020-11-25 | — | — |
Institution
BTIG
Reiterated · Buy · 2026-09-24
$20.00
+46.00%
Citigroup
Upgraded · Neutral → Buy · 2026-09-24
—
—
B. Riley Securities
Upgraded · Neutral → Buy · 2026-03-18
—
—
Piper Sandler
Reiterated · Overweight · 2026-03-04
$25.00
+82.50%
HC Wainwright & Co.
Reiterated · Neutral · 2025-11-11
—
—
Wells Fargo
Reiterated · Overweight · 2025-10-23
—
—
Guggenheim
Downgraded · Buy → Neutral · 2025-10-23
—
—
Leerink Partners
Reiterated · Outperform · 2025-08-22
$54.00
+294.20%
Scotiabank
Reiterated · Sector Outperform · 2025-07-02
$32.00
+133.60%
Canaccord Genuity
Reiterated · Buy · 2025-05-13
$74.00
+440.10%
Cantor Fitzgerald
Reiterated · Overweight · 2025-03-07
—
—
Goldman Sachs
Reiterated · Sell · 2022-11-10
$14.00
+2.20%
Baird
Downgraded · Neutral → Underperform · 2022-11-10
—
—
Barclays
Upgraded · Underweight → Equal Weight · 2022-11-02
$25.00
+82.50%
Raymond James
Downgraded · Market Perform → Underperform · 2022-08-10
—
—
B. Riley FBR
Downgraded · Buy → Neutral · 2021-01-15
—
—
Roth Capital
Downgraded · Buy → Sell · 2020-12-23
$41.00
+199.30%
WBB Securities
Downgraded · Strong Buy → Hold · 2020-11-25
—
—
Ladenburg Thalmann
Downgraded · Buy → Neutral · 2020-11-25
—
—
H.C. Wainwright
Reiterated · Buy · 2020-11-25
$60.00
+338.00%
Miller Tabak
Downgraded · Strong Buy → Buy · 2020-11-25
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space